Recent progress in pharmaceutical sciences has made it possible for us to live longer and longer. For example, antibiotics and vaccines have been developed that were successfully administered to patients with infectious diseases. A number of effective drugs for specific diseases could be purified from natural resources or created by chemical synthesis, and recent recombinant DNA technologies have brought about antibody-drugs. It seems increasingly possible that a treatment for every disease could be established in the near future. Nevertheless, prevention or remedies for inherited age-related diseases, including cancer, have not yet been completely established. However, recent progresses in human genetics and molecular biology revealed that premature aging is caused by mutations on DNA helicase encoding genes (Bernstein et al., ). These exciting findings have encouraged scientists to research mechanisms of the age-related diseases.
DNA/RNA helicases are enzymes that unwind DNA/DNA, DNA/RNA, and RNA/RNA duplexes to execute and regulate DNA replication, recombination, repair, and transcription (Patel and Donmez, ). To date, numerous genes have been identified to encode helicases. Importantly, genetic studies have revealed that mutations in some of these genes are associated with certain human diseases, including Xeroderma Pigmentosum (XP), Cockayne Syndrome (CS), and Werner Syndrome (WS) (Puzianowska-Kuznicka and Kuznicki, ). Given that helicases play an important role in the regulation and maintenance of chromosomal DNAs, it might not be so difficult to understand that their dysfunction leads to unfavorable states. Nuclear events, such as nucleotide excision repair (NER), transcription coupled repair (TCR), and telomere maintenance, are thought to be individually affected by XPB/XPD, CSA/CSB and WRN helicases, respectively (Table 1). Because epigenetic changes and disruption of chromosomal integrity have been strongly suggested to correlate with cellular senescence, these helicases may be important factors to regulate aging and age-related diseases.
Table 1
| Helicase (GENE ID) | Disease | References |
|---|---|---|
| BLM (BLM) | BSa,b | Ellis et al., |
| CSA (ERCC8), CSB (ERCC6) | CSa,d | Henning et al., |
| DDX11 (DDX11) | Warsaw breakage syndromed | van der Lelij et al., |
| FANCJ (BRIP1) | FAb,c | Levitus et al., |
| IGHMBP2 (IGHMBP2) | SMARD1d, CMT2d | Grohmann et al., ; Cottenie et al., |
| IFIH1 (IFIH1) | SLEe | Robinson et al., |
| MCM4 (MCM4) | NKGCD, cancer | Hughes et al., ; Jackson et al., |
| RECQ1/RECQL1 (RECQL) | Cancer | Sharma and Brosh, |
| RECQL4 (RECQL4) | RTSa,b | Kitao et al., |
| RTEL1 (RTEL1) | HHSb,c,f | Ballew et al., |
| SETX (SETX) | ALS4d | Chen et al., |
| TWINKLE (c10orf2) | MDS7d | Spelbrink et al., |
| WRN (WRN) | WSa,b,f | Oshima et al., |
| XPB (ERCC3), XPD (ERCC2) | XPb, CSa,d | Sung et al., ; Hwang et al., |
Helicases that associate with human diseases.
Premature aging.
Cancer or risk of cancer.
Bone marrow failure.
Impaired development of nervous system or deficiencies in neuromuscular junctions.
Autoimmune disease.
Telomere shortening.
ALS, amyotrophic lateral sclerosis; BS, Bloom syndrome; CMT, Charcot-Marie-Tooth disease; CS, Cockayne syndrome; FA, Fanconi anemia; HHS, Hoyeraal Hreidarsson syndrome (Dyskeratosis congenita); MDS, Mitochondrial DNA depletion syndrome; NKGCD, Natural killer cell and glucocorticoid deficiency with DNA repair defect; SLE, systemic lupus erythematosus; RTS, Rothmund-Thomson syndrome; SMARD1, spinal muscular atrophy with respiratory distress type 1; WS, Werner syndrome; XP, Xeroderma pigmentosum.
Despite great efforts being made to elucidate the properties of helicases on a molecular and cellular level, it seems that the gap from molecule to patient is still distant. In this research topic, authors have described and discussed the forefront of the helicase studies. It is very important to establish a molecular model of how helicases interact with DNA repair machinery. In the research topic, the properties of the FANCJ (BRIP1) that affect cancer and Fanconi Anemia (FA) development have been summarized (Brosh and Cantor, ). In order to assess the mechanisms of diseases, including cancer, which are caused by dysfunctions of helicases, several approaches could be applied. Genetic and expression analyses of samples from patients will enable us to discuss the alterations in both the quality of DNA and the quantity of RNA. Therefore, diagnosis/prognosis of cancer or age-related diseases will be possible by analyzing the RECQ1 (RECQL) gene expression (Sharma, ). Based on the concept that helicases play important roles in the maintenance of chromosomal DNAs, novel therapeutics will be applicable for cancer therapy with siRNAs of the RECQL1 (RECQL) and WRN DNA helicase-encoding genes (Futami and Furuichi, ). The therapy is supported by experimental results showing that siRNA of the RECQL could be effectively applied for ovarian cancer treatment by inducing apoptosis (Matsushita et al., ). Structural analyses of the helicase protein molecules will provide their precise function in the process of DNA repair. The precise molecular structure models of the WRN and BLM helicases will contribute for a development of rational design of specific drugs to prevent aging and cancer (Kitano, ). Moreover, establishment of iPSCs from helicase deficient cells will contribute to the clinical tests to develop novel drugs that delay aging and age-related diseases (Shimamoto et al., ). Furthermore, studies on RNA helicases, especially those that are involved in immune responses, will contribute to developing strategies against viral infections. It was shown that DDX3 could be a novel therapeutic target for HIV-1 and HCV replication (Ariumi, ). Importantly, IFIH1, which controls anti-viral responses, will be a molecular target of diagnosis and treatment for systemic lupus erythematosus (SLE) (Oliveira et al., ). All these articles provide new insights into the molecular pathology of the helicase-associated diseases. Further studies on various helicases will not only contribute to diagnoses and treatment of specific diseases (Table 1) but also to prevention and next generation-therapeutics on cancer and age-related diseases.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AriumiY. (2014). Multiple functions of DDX3 RNA helicase in gene regulation, tumoligenesis, and viral infection. Front. Genet. 5:423. 10.3389/fgene.2014.00423
2
BallewB. J.YeagerM.JacobsK.GiriN.BolandJ.BurdettL.et al. (2013). Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in dyskeratosis congenita. Hum. Genet. 132, 473–480. 10.1007/s00439-013-1265-8
3
BernsteinK. A.GangloffS.RothsteinR. (2010). The RecQ DNA helicases in DNA repair. Annu. Rev. Genet. 44, 393–417. 10.1146/annurev-genet-102209-163602
4
BroshR. M.Jr.CantorS. B. (2014). Molecular and cellular functions of the FANCJ DNA helicase defective in cancer and in Fanconi anemia. Front. Genet. 5:372. 10.3389/fgene.2014.00372
5
ChenY. Z.BennettC. L.HuynhH. M.BlairI. P.PulsI.IrobiJ.et al. (2004). DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74, 1128–1135. 10.1086/421054
6
CottenieE.KochanskiA.JordanovaA.BansagiB.ZimonM.HorgaA.et al. (2014). Truncating and missense mutations in IGHMBP2 cause Charcot-Marie tooth disease type 2. Am. J. Hum. Genet. 95, 590–601. 10.1016/j.ajhg.2014.10.002
7
EllisN. A.GrodenJ.YeT. Z.StraughenJ.LennonD. J.CiocciS.et al. (1995). The Bloom's syndrome gene product is homologous to RecQ helicases. Cell83, 655–666. 10.1016/0092-8674(95)90105-1
8
FutamiK.FuruichiY. (2015). RECQL1 and WRN DNA repair helicases: potential therapeutic targets and proliferative markers against cancers. Front. Genet. 5:441. 10.3389/fgene.2014.00441
9
GrohmannK.SchuelkeM.DiersA.HoffmannK.LuckeB.AdamsC.et al. (2001). Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat. Genet. 29, 75–77. 10.1038/ng703
10
HenningK. A.LiL.IyerN.McDanielL. D.ReaganM. S.LegerskiR.et al. (1995). The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell82, 555–564. 10.1016/0092-8674(95)90028-4
11
HughesC. R.GuastiL.MeimaridouE.ChuangC.-H.SchimentiJ. C.KingP. J.et al. (2012). MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J. Clin. Invest. 122, 814–820. 10.1172/JCI60224
12
HwangJ. R.MoncollinV.VermeulenW.SerozT.van VuurenH.HoeijmakersJ. H.et al. (1996). A 3′ –> 5′ XPB helicase defect in repair/transcription factor TFIIH of xeroderma pigmentosum group B affects both DNA repair and transcription. J. Biol. Chem. 271, 15898–15904. 10.1074/jbc.271.27.15898
13
JacksonA. P.LaskeyR. A.ColemanN. (2014). Replication proteins and human disease, in DNA Replication, eds BellS. D.MechaliM.DePamphilisM. L. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press), 327–342.
14
KitanoK. (2014). Structural mechanisms of human RecQ helicases WRN and BLM. Front. Genet. 5:366. 10.3389/fgene.2014.00366
15
KitaoS.ShimamotoA.GotoM.MillerR. W.SmithsonW. A.LindorN. M.et al. (1999). Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome. Nat. Genet. 22, 82–84. 10.1038/8788
16
LevitusM.WaisfiszQ.GodthelpB. C.de VriesY.HussainS.WiegantW. W.et al. (2005). The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet. 37, 934–935. 10.1038/ng1625
17
MatsushitaY.YokoyamaY.YoshidaH.OsawaY.MizunumaM.ShigetoT.et al. (2014). The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer. J. Ovarian. Res. 7:107. 10.1186/s13048-014-0107-1
18
OliveiraL.SinicatoN. A.PostalM.AppenzellerS.NiewoldT. B. (2014). Dysregulation of antiviral helicase pathways in systemic lupus erythematosus. Front. Genet. 5:418. 10.3389/fgene.2014.00418
19
OshimaJ.YuC. E.PiussanC.KleinG.JabkowskiJ.BalciS.et al. (1996). Homozygous and compound heterozygous mutations at the Werner syndrome locus. Hum. Mol. Genet. 5, 1909–1913. 10.1093/hmg/5.12.1909
20
PatelS. S.DonmezI. (2006). Mechanisms of helicases. J. Biol. Chem. 281, 18265–18268. 10.1074/jbc.R600008200
21
Puzianowska-KuznickaM.KuznickiJ. (2005). Genetic alterations in accelerated ageing syndromes. Do they play a role in natural ageing?Int. J. Biochem. Cell Biol. 37, 947–960. 10.1016/j.biocel.2004.10.011
22
RobinsonT.KariukiS. N.FranekB. S.KumabeM.KumarA. A.BadaraccoM.et al. (2011). Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients. J. Immunol. 187, 1298–1303. 10.4049/jimmunol.1100857
23
SharmaS. (2014). An appraisal of RECQ1 expression in cancer progression. Front. Genet. 5:426. 10.3389/fgene.2014.00426
24
SharmaS.BroshR. M.Jr. (2008). Unique and important consequences of RECQ1 deficiency in mammalian cells. Cell Cycle7, 989–1000. 10.4161/cc.7.8.5707
25
ShimamotoA.YokoteK.TaharaH. (2015). Werner syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming. Front. Genet. 6:10. 10.3389/fgene.2015.00010
26
SpelbrinkJ. N.LiF. Y.TirantiV.NikaliK.YuanQ. P.TariqM.et al. (2001). Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat. Genet. 28, 223–231. 10.1038/90058
27
SungP.BaillyV.WeberC.ThompsonL. H.PrakashL.PrakashS. (1993). Human xeroderma pigmentosum group D gene encodes a DNA helicase. Nature365, 852–855. 10.1038/365852a0
28
van der LelijP.ChrzanowskaK. H.GodthelpB. C.RooimansM. A.OostraA. B.StummM.et al. (2010). Warsaw breakage syndrome, a cohesinopathy associated with mutations in the XPD helicase family member DDX11/ChIR1. Am. J. Hum. Genet. 86, 262–266. 10.1016/j.ajhg.2010.01.008
Summary
Keywords
helicasees, genetic diseases, RecQ helicases, Fanconi Anemia, premature aging, cancer, RNA helicases
Citation
Uchiumi F, Seki M and Furuichi Y (2015) Helicases and human diseases. Front. Genet. 6:39. doi: 10.3389/fgene.2015.00039
Received
22 January 2015
Accepted
26 January 2015
Published
12 February 2015
Volume
6 - 2015
Edited and reviewed by
Blanka Rogina, University of Connecticut Health Center, USA
Copyright
© 2015 Uchiumi, Seki and Furuichi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: uchiumi@rs.noda.tus.ac.jp
This article was submitted to Genetics of Aging, a section of the journal Frontiers in Genetics.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.